Interleukin 15 in Cell-Based Cancer Immunotherapy von Zhou, Yang, Husman, Tiffany, Cen, Xinjian, Tsao, Tasha, Brown, James, Bajpai, Aarushi, Li, Miao, Zhou, Kuangyi, Yang, Lili

Volltext

Engineering Induced Pluripotent Stem Cells for Cancer Immunotherapy von Zhou, Yang, Li, Miao, Zhou, Kuangyi, Brown, James, Tsao, Tasha, Cen, Xinjian, Husman, Tiffany, Bajpai, Aarushi, Dunn, Zachary Spencer, Yang, Lili

Volltext

Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy von Li, Yan-Ruide, Zhou, Yang, Kim, Yu Jeong, Zhu, Yanni, Ma, Feiyang, Yu, Jiaji, Wang, Yu-Chen, Chen, Xianhui, Li, Zhe, Zeng, Samuel, Wang, Xi, Lee, Derek, Ku, Josh, Tsao, Tasha, Hardoy, Christian, Huang, Jie, Cheng, Donghui, Montel-Hagen, Amélie, Seet, Christopher S., Crooks, Gay M., Larson, Sarah M., Sasine, Joshua P., Wang, Xiaoyan, Pellegrini, Matteo, Ribas, Antoni, Kohn, Donald B., Witte, Owen, Wang, Pin, Yang, Lili

Volltext

Lung Allograft Epithelium DNA Methylation Age Is Associated With Graft Chronologic Age and Primary Graft Dysfunction von Dugger, Daniel T., Calabrese, Daniel R., Gao, Ying, Deiter, Fred, Tsao, Tasha, Maheshwari, Julia, Hays, Steven R., Leard, Lorriana, Kleinhenz, Mary Ellen, Shah, Rupal, Golden, Jeff, Kukreja, Jasleen, Gordon, Erin D., Singer, Jonathan P., Greenland, John R.

Volltext

CCR5 drives NK cell-associated airway damage in pulmonary ischemia-reperfusion injury von Santos, Jesse, Wang, Ping, Shemesh, Avishai, Liu, Fengchun, Tsao, Tasha, Aguilar, Oscar A, Cleary, Simon J, Singer, Jonathan P, Gao, Ying, Hays, Steven R, Golden, Jeffrey A, Leard, Lorriana, Kleinhenz, Mary Ellen, Kolaitis, Nicholas A, Shah, Rupal, Venado, Aida, Kukreja, Jasleen, Weigt, S Sam, Belperio, John A, Lanier, Lewis L, Looney, Mark R, Greenland, John R, Calabrese, Daniel R

Volltext

NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes von Calabrese, Daniel R, Tsao, Tasha, Magnen, Mélia, Valet, Colin, Gao, Ying, Mallavia, Beñat, Tian, Jennifer J, Aminian, Emily A, Wang, Kristin M, Shemesh, Avishai, Punzalan, Elman B, Sarma, Aartik, Calfee, Carolyn S, Christenson, Stephanie A, Langelier, Charles R, Hays, Steven R, Golden, Jeffrey A, Leard, Lorriana E, Kleinhenz, Mary Ellen, Kolaitis, Nicholas A, Shah, Rupal, Venado, Aida, Lanier, Lewis L, Greenland, John R, Sayah, David M, Ardehali, Abbas, Kukreja, Jasleen, Weigt, S Samuel, Belperio, John A, Singer, Jonathan P, Looney, Mark R

Volltext

Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer von Zhu, Yanni, Smith, Drake J., Zhou, Yang, Li, Yan-Ruide, Yu, Jiaji, Lee, Derek, Wang, Yu-Chen, Di Biase, Stefano, Wang, Xi, Hardoy, Christian, Ku, Josh, Tsao, Tasha, Lin, Levina J., Pham, Alexander T., Moon, Heesung, McLaughlin, Jami, Cheng, Donghui, Hollis, Roger P., Campo-Fernandez, Beatriz, Urbinati, Fabrizia, Wei, Liu, Pang, Larry, Rezek, Valerie, Berent-Maoz, Beata, Macabali, Mignonette H., Gjertson, David, Wang, Xiaoyan, Galic, Zoran, Kitchen, Scott G., An, Dong Sung, Hu-Lieskovan, Siwen, Kaplan-Lefko, Paula J., De Oliveira, Satiro N., Seet, Christopher S., Larson, Sarah M., Forman, Stephen J., Heath, James R., Zack, Jerome A., Crooks, Gay M., Radu, Caius G., Ribas, Antoni, Kohn, Donald B., Witte, Owen N., Yang, Lili

Volltext